This article in the April 26 ACRP Wire highlights a new study from ICON and Booz & Company that provides insight into how to successfully structure relationships between CROs and pharmaceutical companies. Read the study here.

In this April 2012 Monitor article, the authors posit that opportunities exist for sponsors and study teams to engage positively with potential and active trial participants by applying patient-centric principles to all stages of clinical trials.

In this Winter 2012 International Clinical Trials article, the authors underline the impact of risk and uncertainty in the bid process for  CROs, and suggest that adopting a risk management strategy is the best  way to overcome potential challenges.

An article in the March 15 ACRP Wire reports that a new survey from Booz & Company has found that more biopharmaceutical companies plan to outsource research and development and clinical trials and shift this work overseas. View the survey here.

This Oliver Wyman report highlights the fall in pharmaceutical R&D productivity in recent years and encourages the industry to rethink its current mindset.

This December 2011 Monitor Article highlights the consequences of noncompliance and outlines key attributes of quality by design and quality risk management approaches.